| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Loracarbef 100mg/5mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Loracarbef 200mg/5mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing cefdinir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cefdinir 25 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing cefepime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely cefepime (as cefepime hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cefixime 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ceftibuten 400 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ceftibuten 18 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely ceftibuten 36 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ceftizoxime sodium 500mg injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ceftizoxime sodium 1g injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing cefditoren (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely cefditoren pivoxil 200 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely piperacillin (as piperacillin sodium) 3 gram and tazobactam (as tazobactam sodium) 375 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ticarcillin 3g/clavulanic acid 100mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amoxicillin 800 mg and clavulanate potassium 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amoxicillin + clavulanate potassium 200mg/28.5mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amoxicillin + clavulanate potassium 250mg/62.5mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amoxicillin + clavulanate potassium 400mg/57mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Co-amoxiclav 200mg/28.5mg/5mL s/f suspension (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely ampicillin (as ampicillin sodium) 125 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely ampicillin (as ampicillin sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ampicillin (as ampicillin sodium) 1 g powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ampicillin (as ampicillin sodium) 1 g and sulbactam (as sulbactam sodium) 500 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely ampicillin (as ampicillin sodium) 2 gram and sulbactam (as sulbactam sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Mezlocillin sodium 1g powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Mezlocillin sodium 2g powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Mezlocillin sodium 3g powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Mezlocillin sodium 4g powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Penicillin G 1,000,000unit injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Penicillin G 2,000,000unit injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Penicillin G 3,000,000unit injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Penicillin G 5,000,000unit injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Penicillin G 10,000,000unit injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Penicillin G procaine 1,200,000unit injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Penicillin G procaine 2,400,000unit injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Penicillin G benzathine 2,400,000unit/4mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Penicillin G benzathine 1,200,000unit/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely phenoxymethylpenicillin potassium 500 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely cloxacillin sodium 250 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely cloxacillin sodium 500 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cloxacillin sodium 125mg/5mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dicloxacillin sodium 125 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely chloramphenicol 5 milligram/1 milliliter conventional release ear solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely doxycycline 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tobramycin 240mg/6mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Gentamicin 240mg/6mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clindamycin hcl 300mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clindamycin 75mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clindamycin 10mg/mL gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely lincomycin hydrochloride 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Azithromycin 1g/packet oral |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely azithromycin (as azithromycin dihydrate) 500 milligram/1 vial powder for conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dirithromycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dirithromycin 250mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely erythromycin 333 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Erythromycin 333mg polymer coated particle tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Erythromycin 500mg polymer coated particle tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Erythromycin 250mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Erythromycin estolate 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely erythromycin estolate 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Erythromycin ethyl succinate 200 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Erythromycin gluceptate 1g injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Troleandomycin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Troleandomycin 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing meclocycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Meclocycline sulfosalicylate 1% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing novobiocin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely novobiocin sodium 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Linezolid 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Colistimethate sodium 150mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely enoxacin 200 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely enoxacin 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Gatifloxacin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Gatifloxacin 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Gatifloxacin 10mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Gatifloxacin 2mg/mL infusion solution 100mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Gatifloxacin 2mg/mL infusion 200mL bag (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levofloxacin 750 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levofloxacin 25mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levofloxacin 25mg/mL injection 30mL vial (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing moxifloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely nalidixic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ofloxacin 4mg/mL injection 50mL bag (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ofloxacin 40mg/mL injection 10mL vial (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ofloxacin 4mg/mL injection 100mL bag (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sparfloxacin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing trovafloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely trovafloxacin mesilate 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Alatrofloxacin mesylate 5mg/mL injection solution 40mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Alatrofloxacin mesylate 5mg/mL injection solution 60mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely tetracycline 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tetracycline 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tetracycline 25 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Spectinomycin 2g injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Mafenide acetate 85mg/g cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Mafenide acetate 5% solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sulfacetamide 15% ophthalmic drop |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sulfacetamide 10% lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]